Proteasome Inhibitors and Their Potential Applicability in Osteosarcoma Treatment

SIMPLE SUMMARY: Bone cancer has seen minimal benefits in therapeutic options in the past 30 years. Proteasome inhibitors present a new avenue of research for the treatment of bone cancer. Proteasome inhibitors impair the function of the proteasome, a structure within the cell that removes unwanted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Stiphout, Cassidy M., Luu, Anita K., Viloria-Petit, Alicia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559645/
https://www.ncbi.nlm.nih.gov/pubmed/36230467
http://dx.doi.org/10.3390/cancers14194544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559645/
https://www.ncbi.nlm.nih.gov/pubmed/36230467
http://dx.doi.org/10.3390/cancers14194544

Ejemplares similares